- Research article
- Open Access
- Open Peer Review
A survey of transcutaneous blood gas monitoring among European neonatal intensive care units
BMC Pediatricsvolume 5, Article number: 30 (2005)
PCO2 and PO2 are important monitoring parameters in neonatal intensive care units (NICU). Compared to conventional blood gas measurements that cause significant blood loss in preterms, transcutaneous (tc) measurements allow continuous, non-invasive monitoring of blood gas levels. The aim of the study was to survey the usage and opinions among German speaking NICUs concerning tc blood gas monitoring.
A questionnaire was developed and sent to 56 head nurses of different NICUs in Germany, Switzerland and Austria.
A completely answered questionnaire was obtained from 41 NICUs. In two of these units tc measurements are not performed. In most NICUs (77%), both PtcO2 and PtcCO2 are measured simultaneously. Most units change the sensors every 3 hours; however, the recommended temperature of 44°C is used in only 15% of units. In only 8% of units are arterial blood gases obtained to validate tc values. Large variations were found concerning the targeted level of oxygen saturation [median upper limit: 95% (range 80–100%); median lower limit: 86% (range 75–93%)] and PO2 [median upper limit: 70 mmHg (range 45–90 mmHg); median lower limit: 44 mmHg (range 30–60 mmHg)].
Our survey shows that the use of tc monitors remains widespread among German speaking NICUs, despite earlier data suggesting that their use had been abandoned in many NICUs worldwide. In addition, we suggest that the current method of monitoring oxygenation may not prevent hyperoxemia in preterm infants.
Preterm infants are vulnerable to alterations in arterial oxygen or carbon dioxide tension . Changes in oxygen supply contribute to the subsequent development of retinopathy of prematurity or bronchopulmonary dysplasia . Hypocarbia has been associated with the subsequent development of periventricular leucomalacia  and cerebral palsy , and while hypercarbia may protect the perinatal brain from hypoxemic-ischemic damage [5, 6], it could also cause retardation of retinal vascularization .
Despite an ongoing discussion concerning the optimal values of blood gas levels, there is consensus that the partial pressures of arterial oxygen and carbon dioxide (PaO2 and PaCO2) should be kept within a narrow range. Thus, intermittent or continuous determination of blood gases is required. However, the repeated arterial blood sampling that is required for the correct measurement of PaO2 and PaCO2 is difficult to perform in preterm infants because the usage of indwelling catheters is associated with complications and significant blood loss. Capillary blood samples, which are painful but easier to obtain, provide satisfactory values for PaCO2 but tend to underestimate PaO2 .
Transcutaneous (tc) measurement of oxygen (PtcO2) and carbon dioxide (PtcCO2) tension is a non-invasive method that has recently offered some promise . Several studies have shown a good correlation between tc and arterial values [9–11]. However, during routine clinical treatment, several problems – such as burns – appear . Furthermore, a poor correlation between PaO2 and PtcO2 was found under routine clinical conditions . On the basis of these reports, alert letters on the subject of tc PO2 measurements were published by Canadian and British health authorities [13, 14], and after clinical introduction of pulse oximetry, the interest in tc oxygen monitoring decreased was abandoned altogether in many neonatal intensive care units (NICUs) around the world . However, the actual status of tc blood gas monitoring in German speaking NICUs remains unknown.
The present observational study was performed to answer the following questions:
1.) To what extent is tc blood gas monitoring performed in German speaking NICUs?
2.) Given reports that nurses are reluctant to perform tc monitoring because they question its reliability , what are the opinions of nurses concerning the reliability of tc values?
3.) Are there any differences between NICUs concerning technical aspects of tc sensor application?
4.) What methods are used to detect hypo- or hyperoxia and what are the upper and lower limits for oxygen saturation and partial pressure in different NICUs?
The questionnaire consisted of four main parts and is described below. A pre-test of the questionnaire was performed at the authors' institution. Twenty nurses were asked to answer the questions. Four of the questions in the original version were found to be misleading and were reworded for the final version of the questionnaire.
The final questionnaire was sent to NICUs by ordinary mail. To avoid any bias due to differences in national medical regulations, the questionnaire was distributed only in German speaking countries. From a list of 168 university hospitals in Germany, Austria and Switzerland every third unit was chosen (n = 56 units). Because nurses are mainly responsible for the usage of tc equipment, head nurses were asked to answer the questionnaire according to their institutional guidelines.
Usage of tc measurements
The first part of the questionnaire was designed to obtain information concerning the usage of tc measurements. The following questions were included:
1. What aged patients do you mainly care for (only preterm infants / preterms and neonates / neonates and older infants)?
2. On which patients do you perform tc measurements (conventional mechanically ventilated patients / CPAP patients / only supplemental oxygen patients / every patient)?
3. Which parameters do you measure (tc PO2 / tc PCO2 / both)?
4. What manufacturer does the monitoring system come from?
The second part of the questionnaire consisted of questions concerning nursing practice during tc measurements:
1. How often do you change the site of the sensor (every 1 / 2 / 3 hours / more / less frequently)?
2. Do you think the changes violate "minimal handling" practices?
3. Do you use a special treatment for erythematous skin areas?
Technical details of tc monitoring
The third section investigated technical details of tc usage and included the following questions:
1. How often do you change the sensor site?
2. What is the temperature of the sensor?
Accuracy of transcutaneous measurements
The final part of the questionnaire was dedicated to the correlation of tc and invasive blood gas measurements. The following questions were asked:
1. What is your impression concerning the accuracy of tc measurements (good / moderate / poor)?
2. On average, how often do you compare tc values with blood gases (routinely / depending on the values)?
3. What source of blood do you use for validation (capillary / arterial / venous)?
4. Concerning monitoring of oxygenation in preterm infants, which value is more important when estimating hypoxia (saturation / tc PO2) and hyperoxia (saturation / tc PO2)? What are the lower and upper limit values?
Data were analyzed with descriptive statistics using Excel (Microsoft) software. Data are presented as median and range or as relative percentages where appropriate.
The questionnaire was completed by 41 of the 56 NICUs (73%). Among the 41 units with completed questionnaires, 2 did not perform tc measurements and hence were excluded from the subsequent analysis.
The head nurses of the 15 non-responding units were contacted by telephone by which it was confirmed that no tc measurements were performed in 8 units, tc measurements were performed but no further information was voluntarily offered in 4 units, and no information at all was offered in 3 units.
Usage of tc measurements
Most of the evaluated NICUs (28/39) mainly care for preterm and term new-borns. In the remaining 11 NICUs, both new-borns and infants are treated. Most of the units perform tc measurements on mechanically ventilated infants or on infants on continuous positive pressure (CPAP) support (Fig. 1A). About 30% of units also use tc monitoring for infants on supplemental oxygen.
The majority of the answering units use a combination of tc PO2 and tc PCO2 sensors. Some units use either tc PO2 or tc PCO2 and two units use both sensors separately (Fig. 1B).
Devices for tc blood gas measurements were from multiple suppliers; however, Radiometer was the most commonly used manufacturer, followed by Hewlett Packard and Hellige.
Analysis of handling showed that most units change the site of the sensor every 3 hours or even more frequently, 6 of 39 units change the sensor every 4 hours, and 3 of 39 less often than every 4 hours. There was no correlation between frequency of changes and manufacturer.
In 60% of the participating units, nurses considered the changing of the sensor as a discomfort for the patient and a violation of the minimal handling policy.
About one third of the units do not have a special treatment of erythematous sensor areas, whereas the remaining units use various ointment therapies.
Technical details of tc measurements
Large differences were found concerning the technical aspects of tc blood gas monitoring. In 17 of 39 units, sensors are calibrated after each change of sensor site. A routine calibration of the sensor is performed every 4 hours in 8 units and once daily in 11 units.
Sensor temperature mainly depends on the age of the patient; however, in most units the sensor works at a temperature of 43°C. In some units temperatures between 42 and 44°C are used (Fig. 1C).
Individual opinion concerning the accuracy of transcutaneous values
Invasive blood gas measurements are routinely performed for comparison with tc values in 14 of 39 units (Fig. 1D). Blood gases are mainly obtained from capillary blood, with only 8% of units obtaining arterial samples (Fig. 2).
The majority of respondent nurses considered the tc measurements as a good (29/39) or intermediate (9/39) estimate of arterial blood gases, while only one NICU nurse stated that tc measurements lead to poor estimates.
The question concerning hyperoxia and hypoxia detection was answered by only 35 units, but these provided some interesting data. To detect hyperoxia in preterm infants, 16 of the 35 NICUs use only oxygen saturation, 10 use only PtcO2, 8 use both and 1 uses neither method. The median upper limit for saturation was 95% (range 80–100%) and the median upper limit for PtcO2 was 70 mmHg (range 45–90 mmHg).
To detect hypoxia, the majority (24/35) of units use only saturation, whereas 9/35 units use both methods (PtcO2 and saturation) and two units use only invasive blood gas methods. The median lower limit for saturation was 86% (range 75–93%) and the median lower limit for PtcO2 was 44 mmHg (range 30–60 mmHg).
To prevent acute or chronic damage, blood gases must be monitored in preterm infants . Transcutaneous (tc) measurement of blood gases represents a valuable tool for continuous, non-invasive monitoring.
Tc monitoring is associated with several problems and it has been reported that this type of monitoring has been abandoned in many NICUs around the world [15, 16]. Up until now, no data were available concerning the usage of tc monitors in German speaking neonatal units. In our observational study, we received answers from 41 of 56 NICUs approached. Of these, 39 responded that they currently use tc monitoring. Four of the 15 non-responding units also performed tc measurements but did not provide any further information. Thus, our representative survey suggests that at least 43 of 56 NICUs (77%) use tc blood gas monitoring. In six units tc monitoring had been completely abandoned. In contrast to data that suggest a reluctance of nurses to use tc monitoring , our study shows wide acceptance of the technique among NICU nurses. The majority of surveyed nurses stated that the accuracy of the tc readings is mostly reliable. However, the need for frequent changes in sensor sites was considered a violation of the minimal handling policy.
Tc monitoring and pulse oximetry are useful techniques for the non-invasive monitoring of oxygenation in new-borns that require supplemental oxygen. Whereas capillary blood gases and pulsoximetry are sufficient to detect hypoxia, it is not sufficient to use either method to prevent hyperoxia. Nevertheless, in the present survey 16 of 35 NICUs used only saturation to detect hyperoxia. Since pulse oximetry values cannot be used to detect hyperoxia, arterial PO2 should also be measured intermittently. About half of all answering units stated that they perform blood gas analysis exclusively from capillary blood samples, but capillary PO2 estimations can only exclude hypoxia and are insufficient for detecting hyperoxia . Thus, it could be speculated that the current oxygen-monitoring policy of some units exposes infants requiring supplemental oxygen to a higher risk of subsequent development of oxygen associated damage, such as retinopathy .
Large variations were found among the different NICUs with regard to the definition of hypoxia and hyperoxia. The upper limit for oxygen saturation ranged between 80% and 100%, and if tc measurements were used, the upper limit ranged between 45 and 90 mmHg (median 70 mmHg). A similarly wide range was found for the detection of hypoxia with a lower saturation border between 75% and 93% (mean 86%). These differences are substantial and could explain some of the described differences in outcomes of preterm infants . These differences require further investigation and specification. The present data do not allow a differentiation between the target values for infants with supplemental oxygen or those with respiratory support.
The present study included some limitations that are partially associated with the chosen method of obtaining information. First, the study sample is based on the return of completed questionnaires. We achieved a return rate of 73%, which is considered a good result and allows reliable interpretation. Secondly, the questionnaire was not designed to identify an association between the monitoring policy at the institution and the clinical outcome parameters; however, the present study does provide sufficient data to plan an appropriate study protocol to address that question. Finally, the questionnaire was only designed to receive information consistent with institutional guidelines. In some cases, the unique situation of an individual patient could lead to deviations from the general policy. A follow-up study could further specify the use of tc monitoring under different clinical conditions (ventilation, oxygen supply, CPAP) and in different populations (preterm, term infants), and could also include the primary reason for the use of tc monitoring. However, surveys of these factors should be mainly performed among the attending neonatologists.
The present survey provides valuable data concerning the current situation of routine clinical blood gas monitoring in German speaking NICUs and has produced the following conclusions: 1) Transcutaneous blood gas monitoring is frequently used in neonatal intensive care units; 2) large variations exist concerning the targeted range of oxygen saturation or PO2; and 3) in infants requiring supplemental oxygen, the current method of monitoring oxygen may not be sufficient to prevent hyperoxia.
Brouillette RT, Waxman DH: Evaluation of the newborn's blood gas status. Clin Chem. 1997, 43: 215-221.
Saugstad OD: Oxygen toxicity in the neonatal period-a review. Acta Paediatr Scand. 1990, 79: 881-892.
Ambalavanan N, Carlo W: Hypocapnia and hypercarbia in respiratory management of newborn infants. Clin Perinatol. 2002, 28: 517-531. 10.1016/S0095-5108(05)70104-4.
Collins MP, Lorenz JM, Jetton JR, Paneth N: Hypocapnia and other ventilation related risk factors for cerebral palsy in low birth weight infants. Pediatr Res. 2001, 50: 712-719.
Vannucci RC, Towfighi J, Heitjan DF, Brucklacher RM: Carbon dioxide protects the perinatal brain from hypoxic-ischemic damage: an experimental study in the immature rat. Pediatrics. 1995, 95: 868-874.
Mariani G, Cifuentes J, Carlo W: Randomized trial of permissive hypercapnia in preterm infants. Pediatrics. 1999, 104: 1082-1088. 10.1542/peds.104.5.1082.
Holmes JM, Zhang S, Leske DA, Lanier WL: Carbon dioxide-induced retinopathy in the neonatal rat. Curr Eye Res. 1998, 17: 608-616. 10.1076/ceyr.17.6.608.5176.
Eaton T, Rudkin S, Garret JE: The clinical utility of arterialized earlobe capillary blood in the assessment of patients for long-term oxygen therapy. Respir Med. 2001, 95: 655-660. 10.1053/rmed.2001.1118.
Binder N, Atherton H, Thorkelsson T, Hoath SB: Measurement of transcutaneous carbon dioxide in low birthweight infants during the first two weeks of life. Am J Perinatol. 1994, 11: 237-241.
Geven WB, Nagler E, deBoo T, Lemmens W: Combined transcutaneous oxygen, carbon dioxide tensions and end-expired CO2 levels in severely ill newborns. Adv Exp Med Biol. 1987, 220: 115-120.
Lofgren O, Henriksson P, Jacobson L, Johansson O: Transcutaneous PO2 monitoring in neonatal intensive care. Acta Paediatr Scand. 1978, 67: 693-697.
Yip WC, Tay JS, Wong HB, Ho TF: Reliability of transcutaneous oxygen monitoring of critical ill children in a general pediatric unit. Clin Pediatr (Phila). 1983, 22: 431-435.
Health and Welfare Canada HPB: Transcutaneous infant PO2 monitors, Medical Devices Alert No.73. Canada. 1985
Department of Health and Social Security: Transcutaneous oxygen monitors, Hazard Notice. R/M 1069/4493. New York. 1980
Miké V, Krauss A, Ross GS: Doctors and the health industry: a case study of transcutaneous oxygen monitoring in neonatal intensive care. Soc Sci Med. 1996, 42: 1247-1258. 10.1016/0277-9536(95)00222-7.
Miké V, Krauss A, Ross GS: Responsibility for clinical innovation. A case study in neonatal medicine. Eval Health Prof. 1998, 21: 3-26.
McLain BI, Evans J, Dear PR: Comparison of capillary and arterial blood gas measurements on neonates. Arch Dis Child. 1988, 63: 743-747.
Flynn JT, Bancalari E, Snyder F, Goldberg R, Feuer W, Cassady J, Schiffman J, Feldman HI, Bachynski B, Buckley E: A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med. 1992, 326: 1050-1054.
Vohr BR, Wright LL, Dusick AM, Perritt R, Poole WK, Tyson JE, Steichen JJ, Bauer CR, Wilson-Costello DE, Mayes LC: Center differences and outcomes of extremely low birth weight infants. Pediatrics. 2004, 113: 781-789. 10.1542/peds.113.4.781.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/5/30/prepub
The author(s) declare that they have no competing interests.
MR developed the study design and drafted the manuscript. KT conceived the study, developed the study design, distributed the questionnaire and collected the data. GS was significantly involved in drafting and revising the article and contributed to analysis and interpretation of data. HH helped to coordinate the study and to develop the questionnaire. RW contributed to the conception and design of the study and the interpretation of data.
Mario Rüdiger, Kerstin Töpfer contributed equally to this work.